2015
DOI: 10.1016/j.contraception.2014.11.014
|View full text |Cite
|
Sign up to set email alerts
|

Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 24 publications
1
23
0
Order By: Relevance
“…We demonstrate that using both misoprostol and mifepristone as an adjunct to synthetic osmotic dilators, fewer osmotic dilators achieved a similar cervical dilation compared with dilation reported in previous studies in this gestational age group . Thus, this use of medication adjuncts has the potential to decrease the pain and cost associated with osmotic dilator insertion and is consistent with previous work that focused on reducing from two sets of dilators to one . The insertion of fewer osmotic dilators offsets the additional cost of mifepristone without increasing side effects or pain, as mifepristone alone did not increase pre‐procedure pain.…”
Section: Discussionsupporting
confidence: 87%
See 3 more Smart Citations
“…We demonstrate that using both misoprostol and mifepristone as an adjunct to synthetic osmotic dilators, fewer osmotic dilators achieved a similar cervical dilation compared with dilation reported in previous studies in this gestational age group . Thus, this use of medication adjuncts has the potential to decrease the pain and cost associated with osmotic dilator insertion and is consistent with previous work that focused on reducing from two sets of dilators to one . The insertion of fewer osmotic dilators offsets the additional cost of mifepristone without increasing side effects or pain, as mifepristone alone did not increase pre‐procedure pain.…”
Section: Discussionsupporting
confidence: 87%
“…Clinical inferiority was defined a priori as a more than 7‐minute difference in operative time between any of the three distinct cervical preparations. In previous studies, operative procedure times were normally distributed with a standard deviation of ~5 minutes; we rationalised that up to a 7‐minute difference in procedure time would be represent a clinically acceptable difference between groups given the elimination of the additional preoperative time and discomfort associated with osmotic dilator insertion. Fourteen participants per group were required to show equivalence within 7 minutes for the procedure with a one‐sided alpha of 0.025 and power of 0.90.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…18 A recent randomized trial compared overnight osmotic dilators plus mifepristone and misoprostol with 2 days of osmotic dilators plus misoprostol before dilation and evacuation at 19-23 6/7 weeks of gestation and found no difference in procedure time or initial cervical dilation between groups. 19 We hypothesized that adjunctive misoprostol 3 hours preoperatively or mifepristone at the time of osmotic dilator placement would improve cervical preparation before dilation and evacuation at 16-23 6/7 weeks of gestation, making surgery easier and faster than preparation with osmotic dilators alone.…”
mentioning
confidence: 99%